Local Multimodal Analgesia vs Regional Anesthesia for Ankle Fracture
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two methods to manage pain after surgery for certain ankle fractures. It compares local multimodal analgesia (a mix of pain relief drugs given directly at the surgery site) with regional anesthesia (a numbing shot in a larger area). The goal is to determine which method more effectively reduces post-surgery pain. Ideal participants have an isolated rotational ankle fracture requiring surgery and can communicate with the research team. As an Early Phase 1 trial, this research aims to understand how these pain management methods work in people, offering participants a chance to contribute to groundbreaking medical insights.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the research team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that combining pain relievers like morphine and bupivacaine is generally safe for reducing pain during surgeries. Studies report few serious problems with these local anesthesia methods.
For regional anesthesia, which uses bupivacaine to numb a larger area, research indicates it is commonly used in surgeries for broken bones, such as ankles. It is considered safe, though some studies mention the possibility of rebound pain, where pain returns after the anesthesia wears off.
Both treatments are used in surgeries today and are generally well-tolerated.12345Why are researchers excited about this trial's treatments?
Unlike the standard of care for ankle fractures, which often involves regional anesthesia, local multimodal analgesia (LMA) introduces a new approach by combining multiple agents like morphine, ketorolac, and bupivacaine. This blend targets pain through different mechanisms, potentially enhancing pain relief and reducing the need for additional medication. Researchers are excited about LMA because it could offer more comprehensive pain control with fewer side effects compared to single-agent regional anesthesia. Additionally, the inclusion of ketorolac and morphine in LMA could provide both anti-inflammatory and analgesic benefits, making it a promising alternative for managing ankle fracture pain.
What evidence suggests that this trial's treatments could be effective for reducing post-operative pain in ankle fractures?
This trial will compare the effectiveness of local multimodal analgesia with regional anesthesia for pain management after ankle fracture surgery. Research has shown that local multimodal pain relief effectively reduces pain following ankle surgery. Studies have found that this approach lessens pain in the hospital and decreases the need for strong painkillers post-surgery. Patients reported experiencing less pain and requiring fewer pain medications during recovery.
Conversely, regional anesthesia, which participants in this trial may receive, is a well-known method in bone surgeries and effectively relieves pain. It acts quickly and wears off faster, aiding in pain management. Overall, both treatments have shown promise in reducing pain after ankle fracture surgeries.26789Who Is on the Research Team?
Justin Haller, MD
Principal Investigator
University of Utah Orthopaedics
Are You a Good Fit for This Trial?
This trial is for individuals with isolated rotational ankle fractures who need surgery, can give informed consent, and communicate in English or Spanish. It's not for those with drug dependency history, stroke, major neurological issues, other leg fractures, allergies to injection ingredients used in the study, head injuries or open fractures.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either local multimodal analgesia or regional anesthesia for pain management post-surgery
Follow-up
Participants are monitored for pain levels and narcotic usage at 1, 2, 4, 8, and 24 hours post-operatively
Extended Follow-up
Participants are monitored for pain levels and narcotic usage up to 8 weeks post-operatively
What Are the Treatments Tested in This Trial?
Interventions
- Local Multimodal Analgesia
- Regional Anesthesia
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor